The FDA has made a groundbreaking decision to approve a clinical trial studying the effects of high-potency marijuana on post-traumatic stress disorder (PTSD) in veterans.
Introduction The cannabis stock market continues to be a highly volatile sector, affected by rapid changes in regulatory policy, political shifts, and evolving public perception.